| Case | Citation | Year of publication | Age (years)/sex | Etiology of ESRD | Animal exposure | Treatment |
| 1 | 11 | 1987 | 55/F | Hypertension | Cat | Vancomycin, gentamicin | 2 | 12 | 1991 | 55/M | Polyarteritis nodosa | Cat | Vancomycin, gentamicin, ciprofloxacin | 3 | 13 | 1991 | 54/M | Hypertension | Cat | Vancomycin, gentamicin, cefazolin | 4 | 14 | 1991 | 25/M | Alport syndrome | Cat | Gentamicin, cephradine | 5 | 15 | 1996 | 75/M | Hypertension | Cat | Vancomycin, cefamandole | 6 | 16 | 1996 | 42/F | Hypertension | Cat | Vancomycin, gentamicin, penicillin | 7 | 17 | 1997 | 12/F | Focal segmental glomerulosclerosis | Cat | Cephapirin, gentamicin | 8 | 18 | 1997 | 73/M | Chronic glomerulonephritis | Cat | Vancomycin, ceftazidime | 9 | 19 | 1998 | 55/M | Polyarteritis nodosa | Cat | Vancomycin, gentamicin, ampicillin-sulbactam | 10 | 20 | 1998 | 47/F | Type 1 diabetes mellitus | Cat | Piperacillin, ciprofloxacin | 11 | 21 | 1999 | 49/M | IgA nephropathy | Cat | Cefazolin, tobramycin | 12 | 22 | 1999 | 18/M | Interstitial nephritis | Cat | Ticarcillin, clindamycin | 13 | 23 | 2000 | 69/F | — | — | — | 14 | 23 | 2000 | 46/F | — | — | — | 15 | 23 | 2000 | 64/M | — | — | — | 16 | 24 | 2000 | 22/F | Medullary cystic kidney disease | Cat | Vancomycin, amikacin, ciprofloxacin | 17 | 25 | 2002 | 24/F | Chronic pyelonephritis | Cat | Ciprofloxacin | 18 | 26 | 2004 | 48/F | — | Cat | Cefazolin, gentamicin, ampicillin | 19 | 7 | 2004 | 73/F | Autosomal dominant polycystic kidney disease | Cat | Vancomycin, gentamicin, Ciprofloxacin | 20 | 27 | 2005 | 52/M | IgA nephropathy | Cat | Amikacin, cefazolin | 21 | 28 | 2005 | 21/F | Congenital small kidneys | Cat | Gentamicin, ceftazidime | 22 | 28 | 2005 | 58/M | Cyclosporine nephrotoxicity | Cat | Gentamicin, vancomycin | 23 | 29 | 2006 | 46/F | — | Cat | Ceftazidime | 24 | 30 | 2007 | 48/F | — | Dog | Cefazolin, gentamicin | 25 | 31 | 2008 | 29/F | — | Cat | Cefazolin, tobramycin | 26 | 6 | 2010 | 38/M | ANCA-related vasculitis | Cat | Ampicillin, levofloxacin | 27 | 10 | 2010 | 36/F | Systemic lupus erythematosus, diabetes mellitus, hypertension | Cat | Ciprofloxacin | 28 | 32 | 2010 | 58/M | Type 2 diabetes mellitus | Cat | Cefazolin, ceftazidime | 29 | 2 | 2012 | 45/M | IgA nephropathy | Cat | Vancomycin, ceftazidime, levofloxacin | 30 | 33 | 2012 | 57/M | Autosomal dominant polycystic kidney disease | Cat, dog | Vancomycin, ceftazidime | 31 | 34 | 2013 | 49/M | Diabetes mellitus | Cat, dog | Vancomycin, tobramycin, cefazolin, ceftazidime, amoxicillin/clavulanate | 32 | 4 | 2013 | 7/F | CKD secondary to prior cardiac arrest | Cat | Ampicillin | 33 | 3 | 2014 | 62/F | Hypertension | Cat | Ciprofloxacin, trimethoprim-sulfamethoxazole, cephalothin | 34 | 5 | 2014 | 25/F | — | Cat | Cefazolin, gentamicin | 35 | 35 | 2015 | 28/F | Hypertension, congenital solitary kidney | Cat | Cefazolin, tobramycin, ceftazidime | 36 | 35 | 2015 | 37/M | Diabetes mellitus | Cat | Cefazolin, tobramycin | 37 | 35 | 2015 | 41/M | Diabetes mellitus, hypertension | Cat | Cefazolin, tobramycin | 38 | 35 | 2015 | 51/F | Hypertension | Cat | Cefazolin, tobramycin, Amoxicillin-clavulanic acid | 39 | 35 | 2015 | 37/F | Chronic interstitial nephropathy | Cat | Ceftriaxone, amoxicillin | 40 | 35 | 2015 | 59/F | Diabetes mellitus | Cat | Cefazolin, tobramycin, ceftazidime | 41 | 35 | 2015 | 69/F | Diabetes mellitus | Cat | Cefazolin, tobramycin, ceftazidime, amoxicillin/clavulanic acid | 42 | 36 | 2017 | 72/M | Diabetes mellitus | Cat | Vancomycin, ceftazidime | 43 | 9 | 2018 | 3/F | Congenital nephrotic syndrome | Cat | Cefazolin, piperacillin, cefdinir | 44 | Our case | 2019 | 59/M | Glomerulonephritis, failed kidney transplant | Cat | Vancomycin, ceftazidime |
|
|